Charlotte Lozier Institute, Author at Lozier Institute

88 results

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court. In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain health and safety practices that abortion providers are required to follow when prescribing the only FDA-approved abortion drug regimen.

Mary E. Harned, J.D.

August 19, 2020

Please login to bookmark

The “No-Test Medication Abortion” Protocol: Experimenting with Women’s Health

A trend of mounting concern is occurring in abortion provision. When elective induced abortion was legalized in the United States in 1973, one oft-cited motivation was to improve abortion’s safety, as it was frequently claimed that many women were injured and sometimes died from illegal abortions. Recently, abortion advocates have changed their strategy. Whereas once they claimed they wanted abortion to be “safe, legal and rare,” now they favor immediate access and convenience to abortion for all women experiencing unintended pregnancies, regardless of whether it might be more dangerous for a woman, or whether the law prohibits it. Thus, they have begun encouraging women to seek more dangerous, “self-managed” abortions.

Ingrid Skop, M.D., FACOG

July 30, 2020

Please login to bookmark

Addendum to Hyde @ 40: Analyzing the Impact of the Hyde Amendment

Addendum: Since the Charlotte Lozier Institute’s analysis of the Hyde Amendment was published in November of 2016, three states have changed how their Medicaid programs cover elective abortions.

Michael J. New, Ph.D.

July 21, 2020

Please login to bookmark

Designing Babies: Science, Ethics, and Policies of a Post-Genomic Era

At the Center for Bioethics and Human Dignity annual summer conference "Bioethics in Real Life,” Dr. David Prentice and Dr. Tara Sander Lee presented a workshop entitled Designing Babies: Science, Ethics, and Policies of a Post-Genomic Era. Scientific advancements in the fields of genetics, molecular diagnosis, and genetic engineering were introduced so that participants could better understand the benefits, risks, limitations, policies, and potential impact on society. The ethics were carefully evaluated and discussed.

Tara Sander Lee, Ph.D.

David Prentice, Ph.D.

July 20, 2020

Please login to bookmark

Top 7 quotes from dissenting opinions in the June Medical abortion case

On June 29, 2020 the U.S. Supreme Court ruled 5-4 against a Louisiana law requiring abortionists to have admitting privileges at a hospital within 30 miles of where they perform the abortion. Justices Thomas, Alito, Gorsuch, and Kavanaugh dissented, with each writing separate dissenting opinions. Justice Gorsuch joined all of Justice Alito’s dissenting opinion and Justice Thomas and Justice Kavanaugh joined parts of it. Here are 7 of the top quotes from today’s dissenting opinions.

Thomas M. Messner, J.D.

June 30, 2020

Please login to bookmark

After June Medical ruling, meaning of Hellerstedt legal standard remains open question

The Supreme Court's ruling today in the June Medical case does not answer the question whether the free-form balancing test required by the 2016 Hellerstedt decision "supplants" or "supplements" the undue burden test from Casey.

Thomas M. Messner, J.D.

June 29, 2020

Please login to bookmark

Six States and Their Radical Approaches to Abortion Law

In 2019, there was a flurry of activity around abortion laws at the state level on both sides of the abortion debate. While states such as Alabama, Louisiana, and Missouri passed life-affirming legislation, other states went a decidedly different direction in codifying Roe v. Wade into state law and some went even further than the landmark 1973 Supreme Court ruling.

Katey Price Vogel, J.D.

June 25, 2020

Please login to bookmark

A Visual Aid to Viral Infection and Vaccine Production

As a result of the rapid spread of the new coronavirus technically known as SARS-CoV-2, the United States and other governments have begun crash efforts to create an effective vaccine or vaccines against the illness at “warp speed.” An array of candidates for this vaccine have emerged and are in various stages of development and testing. At the same time, questions have emerged about the ways in which these vaccines, reflecting experience across the history of development of these preventives, are produced, including processes to which millions of Americans object on moral grounds. The variety of means used to produce vaccines today is immense, employing both ethically licit and questionable procedures. To assist in understanding these modes of production, we offer this primer on the basic science involved.

David Prentice, Ph.D.

Tara Sander Lee, Ph.D.

June 15, 2020

Please login to bookmark